Company Filing History:
Years Active: 2022
Title: David James Mansell: Innovator in Protein Drug Conjugates
Introduction
David James Mansell is a notable inventor based in Newcastle upon Tyne, GB. He has made significant contributions to the field of biotechnology, particularly in the development of protein drug conjugates. His innovative work focuses on enhancing targeted drug delivery applications, which is crucial for advancing therapeutic methods.
Latest Patents
David James Mansell holds a patent related to "Materials and methods relating to linkers for use in protein drug conjugates." This invention pertains to protein drug conjugates, methods of manufacturing them, and their therapeutic applications. The patent emphasizes the use of a globular protein, an improved linker, and a drug to facilitate targeted drug delivery.
Career Highlights
Mansell is currently associated with Iksuda Therapeutics Limited, where he applies his expertise in biotechnology to develop cutting-edge solutions. His work at Iksuda Therapeutics focuses on creating innovative therapies that leverage the potential of protein drug conjugates.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Anthony David Baxter and Christopher Michael Birchall. These collaborations have further enriched his research and development efforts in the field of biotechnology.
Conclusion
David James Mansell is a pioneering inventor whose work in protein drug conjugates is paving the way for advancements in targeted drug delivery. His contributions are vital for the future of therapeutic applications in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.